aap Implantate AG

XETRA AAQ1.DE

aap Implantate AG EBIT Margin for the year ending December 31, 2023: -43.96%

aap Implantate AG EBIT Margin is -43.96% for the year ending December 31, 2023, a -55.73% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

aap Implantate AG EBIT Margin for the year ending December 31, 2022 was -28.23%, a -45.28% change year over year.
aap Implantate AG EBIT Margin for the year ending December 31, 2021 was -19.43%, a 78.71% change year over year.
aap Implantate AG EBIT Margin for the year ending December 31, 2020 was -91.25%, a 46.25% change year over year.
aap Implantate AG EBIT Margin for the year ending December 31, 2019 was -169.77%, a -140.26% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

XETRA: AAQ1.DE

aap Implantate AG

CEO	Mr. Rubino Di Girolamo
IPO Date	May 11, 1999
Location	Germany
Headquarters	Lorenzweg 5
Employees	87
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Composite Materials Glass Hardware & Electronics Pharmaceuticals Plastics

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Key trends

Past 5 years